chrisvoncsefalvay/vaers-outcomes huggingface dataset:
I started feeling warm, nauseous, headache, muscle aches. My arm was very sore as the evening progressed I was having chills. By the next day I could not get out of bed..it has been five days since flu shot and I am so very weak but feeling beter than yesterday. Spot still sore where shot was given and I still have muscle aches...also for some reason extreme foot pain in my bones.
On 01/10/2022 was feeling unwell and call in urgent care and was tested 01/11/2022 positive COVID, 10 days later 01/22/2022 negative COVID. Experience with COVID mild case cold symptom and tested positive instance clinic and 10 days negative at rite aid drive through clinic. Entire family exposure to COVID and all vaccinated and boosted so did not have a serious issue with COVID case.
Coughing up old mucus; This is a spontaneous report from a contactable consumer or other non hcp. A female patient (reporter mother) of an unspecified age received bnt162b2 (Pfizer-BioNTech COVID-19 mRNA vaccine, Formulation: Solution for injection, Batch/Lot number was not reported), via an unspecified route of administration on 02Feb2021 as unknown, single dose for covid-19 immunisation. The patient medical history was not reported. The patient's concomitant medications were not reported. Reporter stated that patient (her mom) got the vaccine and had the same thing, the old mucus coming up. Reported stated she does not have time to complete a whole report because she needs to go get something to eat.   No further information provided. Information on lot/batch number has been requested.  Follow-up (16Apr2021): This follow-up is being submitted to notify that the lot/batch number is not available despite the follow-up attempts made. Follow-up attempts have been completed and no further information is expected.
Marked axillary lymphadenopathy on the vaccine side.  Significant enough to make it unlikely we will have him get the 2nd  COVID vaccine  I do not take that lightly as I am a physician and vaccine advocate.
This initial spontaneous report was received from a lawyer regarding a case in litigation and refers to a male patient of unknown age. No information was provided regarding concomitant medications, concurrent conditions or medical history. In 2014, the patient was inoculated with ZOSTAVAX at a pharmacy as recommended for routine adult health maintenance and for the prevention of shingles (dose, route, and lot # not provided). The vaccine did not prevent shingles as intended, and the patient subsequently contracted a persistent strain of herpes zoster, also known as shingles and other complications. On or about 16-JAN-2016, the patient was treated by a physician for a blistering vesicular outbreak that was diagnosed as severe herpes zoster or shingles. As a direct and proximate result of ZOSTAVAX vaccine, and/or despite receiving ZOSTAVAX for long-term prevention of shingles, the patient suffered painful injuries and damages, and required extensive medical care and treatment.  As a further proximate result, the patient has suffered and will continue to suffer significant medical expenses, and pain and suffering, and other damages. The outcome of the events was unknown.  Causality assessment was related. Additional information has been requested.
Sudden onset left calf pain 4/2, increasing swelling and pain, presented for evaluation 4/9, SVT and DVT noted on ultrasound same day, started on Eliquis to manage clot.
1st Vaccine given 1/7. Starting 1/13, itching to area of vaccine. Starting 1/14, increasing redness to site of injection. Started approximately the size of a quarter and increase over 24 hours despite hydrocortisone and Benadryl. Area of redness currently 4? x 3.5?, warm to the touch, mild itching. Advised by MD to start Medrol dose pack and monitor symptoms.
No adverse event; Inappropriate schedule of vaccine administered; This spontaneous case was reported by a patient and describes the occurrence of INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Inappropriate schedule of vaccine administered) and NO ADVERSE EVENT (No adverse event) in a 70-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 019B21A and 012A21A) for COVID-19 prophylaxis.     No Medical History information was reported.   On 21-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 03-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 03-Apr-2021, the patient experienced INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Inappropriate schedule of vaccine administered). On an unknown date, the patient experienced NO ADVERSE EVENT (No adverse event). At the time of the report, INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Inappropriate schedule of vaccine administered) and NO ADVERSE EVENT (No adverse event) outcome was unknown.            Concomitant medication details were not reported by the reporter. Treatment details was not reported by the reporter.   This case was linked to MOD-2022-648563 (Patient Link).
Subsequent to receiving second dose of varicella virus vaccine live laboratory evaluation revealed a titer of 0.92 (lack of response). Greater than 1.09 indicated a positive titer. Medical attention was sought. No further information is available.
Last night this itching came back reaching her scalp line, lips, around her eyes, under he arms, around her face, and around her trunk; she felt tingling; itching under her arm on her left deltoid/started itching around her face and waistline; This spontaneous case was reported by a nurse and describes the occurrence of PARAESTHESIA (she felt tingling), PRURITUS (itching under her arm on her left deltoid/started itching around her face and waistline) and PRURITUS (Last night this itching came back reaching her scalp line, lips, around her eyes, under he arms, around her face, and around her trunk) in a 70-year-old female patient who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (batch no. 030G22B) for COVID-19 prophylaxis.     The patient's past medical history included COVID-19 from 09-Jul-2022 to 27-Jul-2022. Previously administered products included for Product used for unknown indication: Flu vaccine (had a similar reaction to flu vaccines in the past.). Past adverse reactions to the above products included Itching with Flu vaccine. Concurrent medical conditions included Drug allergy and Drug allergy. Concomitant products included LEVOCETIRIZINE DIHYDROCHLORIDE (XYZAL) and MONTELUKAST SODIUM (SINGULAIR) for Allergy.    On 04-Oct-2022, the patient received fourth dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Intramuscular) 1 dosage form. On 04-Oct-2022, the patient experienced PARAESTHESIA (she felt tingling) and PRURITUS (itching under her arm on her left deltoid/started itching around her face and waistline). On 05-Oct-2022, the patient experienced PRURITUS (Last night this itching came back reaching her scalp line, lips, around her eyes, under he arms, around her face, and around her trunk). The patient was treated with DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL [DIPHENHYDRAMINE HYDROCHLORIDE]) for Itching, at an unspecified dose and frequency. On 05-Oct-2022, PRURITUS (itching under her arm on her left deltoid/started itching around her face and waistline) had resolved. At the time of the report, PARAESTHESIA (she felt tingling) and PRURITUS (Last night this itching came back reaching her scalp line, lips, around her eyes, under he arms, around her face, and around her trunk) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): In July 2022, SARS-CoV-2 test: (Positive) Positive.     For mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Intramuscular), the reporter did not provide any causality assessments.   Patient has received 3 doses of the Moderna COVID-19 vaccines by intramuscular injection on 3Mar2021 (lot number 013A21A, expiration date unknown), 30Mar2021 (lot number 008B21A,expiration date unknown), and 29Oct2021 (lot number 051F21A, expiration date unknown)  This case was regarding patient has taken bivalent fourth dose.  It was reported that patient took a Benadryl which helped. This medication took the edge off and made the itch go away.   This case was linked to MOD-2022-655850 (Patient Link).
Rash and fever. Fussiness. Began within 24 hrs after vaccines.
Information has been received from a physician concerning a boy who on an unspecified date was vaccinated with VARIVAX (Merck) (lot # not reported). After several year of vaccination, the patient got a case of chickenpox. The patient received unspecified medical attention. At the time of the reporting, the patient's outcome was unknown. Follow up information received from a physician indicating that the information leading to us sending the letter resulted from out representative's misunderstanding. This is one of several reports from the same source. No further information is available.
At time of injection patient had tingling sensation and mild pain in fingers. Pain at injection site as well, more severe than past vaccinations. Two days later she presented back to the pharmacy with a bruise at the injection site and a large red blotchy area approximately one inch below injection site. The red, blotchy area was inflamed and warm to the touch. It measured approximately 1-1/2 by 2-1/2 inches. Continued to have pain in the injection arm.
Patient developed "painful bumps" on unilateral scalp.  She then proceeded to develop shingles rash on face and in mouth.  Her primary care physician diagnosed the rash as shingles.  Patient believes shingles reactions caused by the "shingles shot".
Headache, Myalgia, fatigue Narrative:  missed a few hours of work the day after 2nd dose due to headache, muscle ache, fatigue
Moderate muscle aches, fatigue, headache. Swellings did redness at injection site
Pt developed erythema and swelling around injection site. As the day progressed the redness spread downward. The area is warm and tender to the touch.
Patient began having hives, itching, and hot flashes at 830am. Checked into emergency dept., sent home by manager.
patient c/o chills, body aches(alot in legs and back), whole right arm pain, feels real weak like 2 days into when he had COVID 12/5/20, headache (2hrs after shot)
In the late morning of March 18th,,  3 days after receiving first Pfizer COVID-19  vaccine I experienced blood pressure spike 179/93, dizziness, light headedness, feeling faint, slight nausea. Later that same day at an earlier scheduled doctor's office appointment my symptoms were less pronounced; bp 142/80 per doctor's exam. The blood pressure spike was sudden, unusual and concerning as there was no explanation for the spike.  On the evening of April 9th, , 4 days after receiving second Pfizer COVID-19 vaccine I experienced blood pressure spike (bp 167/98; 163/101) dizziness, chills, very light headed, heart pounding, feeling faint and nausea. The blood pressure spike was sudden, unusual and concerning as there was no explanation for the spike. Before bedtime my BP had dropped to 153/88, heart pounding had ceased, but other symptoms only slightly less pronounced. The following morning BP was back to my general levels 133/85. Light headedness, and nausea persisted but milder.
Elevated resting heart rate. Metoprolol 5mg/day for 5 months
Numbness, tingling, shooting electrical pains down left arm. Lasted few minutes and then stopped. Lasted hours with second vaccine and involved both arms.
I82.4Z3 ACUTE DVT OF BILAT CALVES, UNSPECIFIED VEINS 9/24/2021 CHEST PAIN J96.22 ACUTE ON CHRONIC HYPERCAPNIC RESPIRATORY FAILURE 7/27/2021 CHEST PAIN I82.4Z3 ACUTE DVT OF BILAT CALVES, UNSPECIFIED VEINS 9/24/2021 DYSPNEA J96.22 ACUTE ON CHRONIC HYPERCAPNIC RESPIRATORY FAILURE 7/27/2021 DYSPNEA I82.4Z3 ACUTE DVT OF BILAT CALVES, UNSPECIFIED VEINS 9/24/2021 ISCHEMIC CARDIOMYOPATHY W SYSTOLIC HEART FAILURE STAGE C J96.22 ACUTE ON CHRONIC HYPERCAPNIC RESPIRATORY FAILURE 7/27/2021 ISCHEMIC CARDIOMYOPATHY W SYSTOLIC HEART FAILURE STAGE C I82.4Z3 ACUTE DVT OF BILAT CALVES, UNSPECIFIED VEINS 9/24/2021 CAD (CORONARY ARTERY DISEASE) WO ANGINA J96.22 ACUTE ON CHRONIC HYPERCAPNIC RESPIRATORY FAILURE 7/27/2021 CAD (CORONARY ARTERY DISEASE) WO ANGINA
Symptoms onset on 1 week ( 2/19/2021)from 2nd dose vaccination date.  Severe pain (worst pain in lifetime) in the joint of the collar bone, arm, should, bilaterally, with hand swelling and pain  bilaterally. Symptoms have not been resolved.  Patient visited emergency room on 4/2/2021 and received steroid therapy, which improved symptoms but has now worn off.  Had an appointment with primary care on 4/23/2021, ran blood tests results still pending.
Full blown shingles on back around left side and across abdomen. Commenced on Feb 25, 2019 began prescribed Valacyclovir 500 MG on March 1, 2019 for seven days. Did not relieve pain. Then began prescribed Naproxen Sodium 275 MG for 7 days on 03/13/2019 but still have pain but rash is diminished.
Sore arm; a little run down for a couple of days; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Sore arm) and ASTHENIA (a little run down for a couple of days) in a 58-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 037K20A and 042L20A) for COVID-19 vaccination.     No medical history was provided by the reporter.  Concomitant products included VITAMIN D [VITAMIN D NOS] and POTASSIUM for an unknown indication.   On 16-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 16-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced PAIN IN EXTREMITY (Sore arm) and ASTHENIA (a little run down for a couple of days). The patient was treated with PARACETAMOL (TYLENOL [PARACETAMOL]) for Weakness, at an unspecified dose and frequency. At the time of the report, PAIN IN EXTREMITY (Sore arm) outcome was unknown and ASTHENIA (a little run down for a couple of days) had resolved.        mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) dosing remained unchanged.       After the first dose patient felt a little run down for a couple of days, and then was fine, took some Tylenol and it helped. Also experienced Sore arm   This case was linked to MOD-2021-378491 (Patient Link).
chills x24h, vomiting once, nausea x24h, headache x24h
This infant had a high fever of 103 beginning 9 days after his MMR, lasted 48 hours. Probable febrile seizure x 2. He broke out into a rash 12 days after the vaccine it lasted 24 hours.
Moderna COVID-19 Vaccine EUA- dose given 10 days after BUD for refrigeration.
-Raised area and red along with warmth  -no fever, body aches or chills -itching within 3-5 min
Information has been received from a physician's assistant through the Merck Pregnancy registry concerning a 15 year old female patient with asthma who on 16-JAN-2007, was vaccinated IM with a second dose of Gardasil (Lot# 655617/1447F). Concomitant therapy included albuterol MDI. After the second dose, it was discovered that she was pregnant. No adverse events were noted. On 24-MAY-2007, the patient elected to terminate the pregnancy. The patient was 21 weeks from last menstrual period. On 20-MAY-2007 and 22-MAY-2007, an ultrasound was performed and the results were unknown. At the time of this report, the patient's outcome was unknown. It was also reported on 16-NOV-2006, the patient was vaccinated with a first dose of Gardasil (Lot# 653736/0868F). No product quality complaint was involved. Upon internal review, elective termination was considered to be an other important medical event. Additional information is not to be expected.
Swelling, redness and pain on arm about 2 days after injection. Also experienced malaise and headache. Still has some swelling and redness along with mailaise 7 days after injection, but better. Treated with NSAID's.
sore arm; tiredness; This spontaneous case was reported by a patient and describes the occurrence of PAIN IN EXTREMITY (sore arm) and FATIGUE (tiredness) in a 70-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On an unknown date, the patient received fourth dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form, second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form and first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced PAIN IN EXTREMITY (sore arm) and FATIGUE (tiredness). At the time of the report, PAIN IN EXTREMITY (sore arm) and FATIGUE (tiredness) outcome was unknown. Patient had no allergies. Patient never had COVID positive test or diagnosis. Patient did not have any history relating to mentioned AE and both acute and chronic illnesses at the time of vaccination. Patient did not take any concomitant medication.  Patient experienced sore arm and tiredness in all four doses of Moderna covid-19 vaccinations. No treatment information was provided by the reporter.   This case was linked to MOD-2022-655103 (Patient Link).
6:00 am on 24th - checked temp. wanting to make sure it wasn't high and it was 99.1 and I decided to take one capsule of Tylenol extra Strength. Took on empty stomach and felt nauseated and went and vomited. No other reactions other than fatigue and low appetite and sore arm the rest of the day. Ate less that day and so did get nausea off and on during the day - but not as severe and no more vomiting. 25th - everything resolved.  6/16/21 - estimated date of delivery. 1st pregnancy. Has been a normal pregnancy.
The patient was a lactating mother; The patient was a lactating mother; Fever 102; Malaise; Headache; Body aches; left axillary pain swelling - lymphedema; left axillary pain swelling - lymphedema; left axillary pain swelling - lymphedema; 1st dose of BNT162B2 on 18Dec2020 13:15/2nd dose on 05Jan2021 13:45; This is a spontaneous report from a contactable other healthcare professional (patient) reported for both mother and baby. This is the maternal report. A 35-year-old female patient received 2nd dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number: EK4176), via an unspecified route of administration in left arm on 05Jan2021 13:45 at single dose for Covid-19 immunisation. Medical history included hx mild ehler's danlos syndrome, sulfa and latex sensitivity. No covid-prior-vaccination. No covid-tested-post-vaccination. The patient's concomitant medications included Prenatal. The patient previously received 1st dose of BNT162B2 (lot# EK5730) in left arm on 18Dec2020 13:15 for Covid-19 immunisation. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient experienced fever 102, malaise, severe headache and body aches, left axillary pain swelling - lymphedema on 06Jan2021 12:15. The patient was a lactating mother. The patient underwent lab tests and procedures which included body temperature: 102 on 06Jan2021. The outcome of events was recovering. This case was reported as non-serious.; Sender's Comments: Linked Report(s) : US-PFIZER INC-2021012166 child case
APPROXIMATELY 5 MINUTES AFTER VACCINE ADMINISTERED PATIENT DESCRIBED OR WAS OBSERVED EXPERIENCING THE FOLLOWING: COUGHING, FLUSHING, SOB, SWELLING OF THROAT OR TONGUE. Patient denied wanting a epi-pen administered, denied EMS being called. After pt reported feeling better and being able to swallow, she was given 1 dose of famotidine with a small amount of water. Pt was monitored for greater than 30 minutes and stated she was no longer experiencing the symptoms and returned to work. She was checked on an hour later and stated to be doing fine.
pt recv vax & exp lt arm soreness, redness & swelling & arm was hot to touch;pt has not been able to move arm up & out (abduction) from body for 13 days;pt tx w/Ibuprofen w/some pain relief;scheduled for an appointment w/MD 18OCT96;
Information was received on 15-AUG-2017 from a lawyer regarding a case in litigation concerning a female patient of unknown age. The patient was inoculated with a dose of ZOSTAVAX vaccine on or about 14-JUN-2014 at a pharmacy, as recommended for routine adult health maintenance and for the prevention of shingles. The vaccine did not prevent shingles as intended, but rather caused the patient to contract a persistent strain of herpes zoster. During the year 2016, the patient was treated at a medical center for the onset of a repeated and severe vesicular eruptions accompanied by weakened immune systems, which was diagnosed as herpes zoster. As a direct and proximate result of these malfunctions, the patient suffered painful injuries and damages, and required extensive medical care and treatment. As a further proximate result, the patient suffered and will continue to suffer significant medical expenses, and pain and suffering , and other damages. Additional information has been requested.
Swelling of left upper arm 3.5x5cm erythema, no induration, hot and painful.
her energy was up after the second dose, but that seems to have worn off as of yesterday; This is a spontaneous report from a contactable consumer (parent). A female patient of an unspecified age received BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, formulation solution for injection; Batch/Lot number was not reported) via an unspecified route of administration on an unspecified date as a Dose 2, single for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. The patient previously received BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, formulation solution for injection; Batch/Lot number was not reported) via an unspecified route of administration on an unspecified date as a Dose 1, single for COVID-19 immunization. she had "a tad after the first dose. She mentioned that her energy was up after the second dose, but that seems to have worn off as of yesterday." The outcome of the event was recovering.  Information about lot/batch number has been requested.  Follow-up attempts are completed. No further information was expected.
22MAY97 while preparing the vax nurse splashed some of it in eye;nurse reported initially it did not burn;eye flushed w/water & it started to burn;@ time of report eye was red;
The shot hurt upon injection and then for 15-20 seconds afterward. I bruised for almost 3 weeks and I still have  some pain in the arm, 3 weeks later.
Patient under the age of 18 inadvertently received two doses of Moderna COVID vaccine. Error not noticed until after second dose.
Systemic: Body Aches Generalized-Medium, Systemic: lower back pain and spasms-Medium
very bad reaction; Shaking; uncontrollable freezing; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION COMPLICATION (very bad reaction), TREMOR (Shaking) and FEELING COLD (uncontrollable freezing) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced VACCINATION COMPLICATION (very bad reaction), TREMOR (Shaking) and FEELING COLD (uncontrollable freezing). At the time of the report, VACCINATION COMPLICATION (very bad reaction), TREMOR (Shaking) and FEELING COLD (uncontrollable freezing) outcome was unknown.            No concomitant medications were reported. No treatment medications were reported.
Pt. is a healthcare worker that provides direct patient care . Pt. received the 2nd dose of the Pfizer COVID19 vaccine on 1/12/21. Pt. reports COVID symptom onset starting 4/27/21 and tested COVID positive via PCR NP swab on 4/28/21